Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Medtronic
Cantor Fitzgerald
Federal Trade Commission
AstraZeneca
McKinsey
Argus Health
US Department of Justice
Colorcon

Generated: May 25, 2018

DrugPatentWatch Database Preview

Tolazoline hydrochloride - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for tolazoline hydrochloride and what is the scope of tolazoline hydrochloride freedom to operate?

Tolazoline hydrochloride
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for tolazoline hydrochloride.
Summary for tolazoline hydrochloride
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 1
Bulk Api Vendors: 61
Patent Applications: 406
DailyMed Link:tolazoline hydrochloride at DailyMed
Medical Subject Heading (MeSH) Categories for tolazoline hydrochloride
Synonyms for tolazoline hydrochloride
1H-Imidazole, 4,5-dihydro-2-(phenylmethyl)-, hydrochloride (1:1)
1H-Imidazole, 4,5-dihydro-2-(phenylmethyl)-, monohydrochloride
1H-Imidazole,4,5-dihydro-2-(phenylmethyl)-, hydrochloride (1:1)
2-(phenylmethyl)-4,5-dihydro-1H-imidazole hydrochloride
2-Benzyl-2-imidazoline hydrochloride
2-Benzyl-2-imidazoline monohydrochloride
2-BENZYL-2-IMIDAZOLINEHYDROCHLORIDE
2-benzyl-4,5-dihydro-1H-imidazole hydrochloride
2-benzyl-4,5-dihydro-1H-imidazole;hydrochloride
2-Imidazoline, 2-benzyl-, hydrochloride
2-IMIDAZOLINE, 2-BENZYL-, MONOHYDROCHLORIDE
245547-27-7
4,5-Dihydro-2-(phenylmethyl)-1H-imidazole monohydrochloride
59-97-2
59-98-3 (Parent)
7380-28-1
AC1L1LOU
AC1Q3CJ8
ACMC-1AM64
AI3-52042
AK-81712
AKOS015900184
AKOS028109640
ANW-74107
AOB5344
Arterodyl
BB_SC-6595
Benzazoline HCl
Benzazoline hydrochloride
Benzylimidazoline hydrochloride
C10H12N2.HCl
CAS-59-97-2
CCG-39122
CHEBI:9615
CHEMBL1689
Cloridrato di 2-benzil-4,5-imidazolina
Cloridrato di 2-benzil-4,5-imidazolina [Italian]
CPD000149600
CS-4287
CTK5B0782
D00997
DB-014037
DSSTox_CID_1718
DSSTox_GSID_21718
DSSTox_RID_76292
DTXSID9021718
E669Z6S1JG
EINECS 200-447-3
FT-0601730
HE042453
HMS1568K21
HMS1921E17
HY-A0066A
I14-10561
Imidaline hydrochloride
KB-20934
KS-00000X0B
KS-5261
LS-79575
MCULE-8393678793
MFCD00012693
MLS000559484
MolPort-003-666-292
NC00612
NCGC00016271-01
NCGC00016271-05
NCGC00094795-01
NCGC00094795-02
NE32284
NSC-757353
NSC757353
Opera_ID_1028
Pharmakon1600-01500580
Prestwick_770
Priscoline (TN)
Priscoline hydrochloride
s4124
SAM002589935
SBB000360
SCHEMBL34869
SMR000149600
SPECTRUM1500580
ST013853
ST2416482
TC-162852
TCMDC-125842
Tolavad
Tolazoline (hydrochloride)
Tolazoline chloride
Tolazoline HCl
Tolazoline hydrochloride (JAN/USP)
Tolazoline hydrochloride [JAN]
Tolazoline Hydrochloride 1.0 mg/ml in Methanol (as free base)
Tolazoline hydrochloride, United States Pharmacopeia (USP) Reference Standard
Tolpal
Tox21_110339
Tox21_110339_1
UNII-E669Z6S1JG
V0311
Z1550648768

US Patents and Regulatory Information for tolazoline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis PRISCOLINE tolazoline hydrochloride INJECTABLE;INJECTION 006403-005 Feb 22, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Boehringer Ingelheim
AstraZeneca
Federal Trade Commission
Cipla
Fish and Richardson
Deloitte
Queensland Health
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.